<PAGE>   1
                                                                   Exhibit 10(m)

March 23, 2000


Mr. Charles Henry Weil
8/Rue Cortambert
Paris, France   75116


RE:      Loan Commitment to Integra, Inc.

Dear Charles-Henri:

         The purpose of this letter is to confirm your commitment to provide to
Integra, Inc. (the "Company") a line of credit of up to $2 million in
consideration of a grant to you of warrants as set forth hereafter.

         Draw downs on the line of credit will be based upon a determination of
the Board of Directors of the Company with respect to the need for operating
capital for the Company. It is understood, however, that the Company will be
using its best efforts to arrange with lending institutions an alternative line
of credit as soon as reasonably practicable, and that this line of credit will
terminate and all amounts then due thereunder will be become immediately due and
payable upon closing of such alternative line of credit. In any event, all
amounts due and payable under the line of credit advanced by you will be due and
payable one year from the date hereof, and this line of credit shall then be
deemed terminated.

         Except as set forth above, the terms, conditions, draw down procedures,
interest rate provisions, covenants and events of default under the recently
terminated PNC Bank line of credit shall apply to the line of credit hereunder,
and such documents are hereby incorporated by reference.

         In consideration of your agreement to provide the line of credit
hereunder, the Company hereby grants the following warrant consideration:

         1.       Initial Warrant. Upon effectiveness of this letter agreement,
                  you will be granted by the Company warrants to purchase 50,000
                  shares of the Company's common stock at the price per share of
                  the Company's common stock on the closing date of the
                  Company's annual meeting of shareholders, at which the grants
                  hereunder will be approved. Such warrant shall be exercisable
                  for a ten year period, and the exercise price shall be subject
                  to adjustment in the event of stock splits, stock dividends,
                  recapitalizations and the like. You acknowledge that the
                  warrants and the underlying shares have not been registered
                  under the Securities Act of 1933, and may not be sold or
                  otherwise encumbered without such registration or opinion
<PAGE>   2
                  of counsel for the Company that an exemption to such
                  registration requirements is available.

         2.       Contingent Additional Warrant. In the event that the Company
                  is unable to achieve a replacement line of credit which
                  terminates the line of credit hereunder by June 30, 2000, you
                  will be granted an additional warrant to purchase 50,000
                  shares of the Company's common stock on the same terms and
                  conditions as the warrant described in subparagraph 1, above.

         In the event that for any reason the grant of warrants hereunder is not
approved by the Shareholders at the annual meeting, you will receive cash
consideration equal to the value of the warrants based on conventional valuation
methodologies as applied by PricewaterhouseCoopers or its designee appraisal
firm.

         The commitments under this letter shall become effective upon your
counter-signature to this letter agreement and approval thereof by the Company's
Board of Directors, a meeting respecting which shall be held immediately. Upon
execution hereof and such Board approval, the commitments set forth herein shall
become legally binding on the parties. Such orders will issue in connection with
the Company's financial statements.

                                      Sincerely yours,

                                      INTEGRA, INC.


                                      By:
                                          -------------------------------------
                                            Eric Anderson,
                                            President & Chief Executive Officer


ACCEPTED:



Charles-Henri Weil